# United Airlines Holdings, Inc.: financial statements, quarterly

UAL · Nasdaq · CIK 100517 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ual.md) · [Financials](/companies/ual/financials.md) · [Filings](/companies/ual/filings.md) · [Insiders](/companies/ual/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ual/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.6 d](/filings/0000100517-26-000023.md) | [12.5](/filings/0000100517-25-000091.md) | [15.0](/filings/0000100517-25-000147.md) | [14.8](/filings/0000100517-25-000193.md) | [14.7 d](/filings/0000100517-26-000023.md) | [13.2](/filings/0000100517-26-000091.md) | [15.2](/filings/0000100517-26-000139.md) | [15.2](/filings/0000100517-26-000186.md) | [15.4 d](/filings/0000100517-26-000023.md) | [14.6](/filings/0000100517-26-000091.md) | [17.7](/filings/0000100517-26-000139.md) | [17.9](/filings/0000100517-26-000186.md) |
| Operating income | $bn | [1.0 d](/filings/0000100517-26-000023.md) | [0.1](/filings/0000100517-25-000091.md) | [1.9](/filings/0000100517-25-000147.md) | [1.6](/filings/0000100517-25-000193.md) | [1.5 d](/filings/0000100517-26-000023.md) | [0.6](/filings/0000100517-26-000091.md) | [1.3](/filings/0000100517-26-000139.md) | [1.4](/filings/0000100517-26-000186.md) | [1.4 d](/filings/0000100517-26-000023.md) | [1.0](/filings/0000100517-26-000091.md) | [1.1](/filings/0000100517-26-000139.md) | [1.4](/filings/0000100517-26-000186.md) |
| Interest expense | $bn | [0.5 d](/filings/0000100517-26-000023.md) | [0.5](/filings/0000100517-25-000091.md) | [0.4](/filings/0000100517-25-000147.md) | [0.4](/filings/0000100517-25-000193.md) | [0.4 d](/filings/0000100517-26-000023.md) | [0.4](/filings/0000100517-26-000091.md) | [0.4](/filings/0000100517-26-000139.md) | [0.3](/filings/0000100517-26-000186.md) | [0.3 d](/filings/0000100517-26-000023.md) | [0.3](/filings/0000100517-26-000091.md) | [0.3](/filings/0000100517-26-000139.md) | [0.4](/filings/0000100517-26-000186.md) |
| Income tax | $bn | [0.2 d](/filings/0000100517-26-000023.md) | [(0.0)](/filings/0000100517-25-000091.md) | [0.4](/filings/0000100517-25-000147.md) | [0.3](/filings/0000100517-25-000193.md) | [0.3 d](/filings/0000100517-26-000023.md) | [0.1](/filings/0000100517-26-000091.md) | [0.3](/filings/0000100517-26-000139.md) | [0.3](/filings/0000100517-26-000186.md) | [0.3 d](/filings/0000100517-26-000023.md) | [0.2](/filings/0000100517-26-000091.md) | [0.2](/filings/0000100517-26-000139.md) | [0.3](/filings/0000100517-26-000186.md) |
| Net income | $bn | [0.6 d](/filings/0000100517-26-000023.md) | [(0.1)](/filings/0000100517-25-000091.md) | [1.3](/filings/0000100517-25-000147.md) | [1.0](/filings/0000100517-25-000193.md) | [1.0 d](/filings/0000100517-26-000023.md) | [0.4](/filings/0000100517-26-000091.md) | [1.0](/filings/0000100517-26-000139.md) | [0.9](/filings/0000100517-26-000186.md) | [1.0 d](/filings/0000100517-26-000023.md) | [0.7](/filings/0000100517-26-000091.md) | [0.8](/filings/0000100517-26-000139.md) | [1.0](/filings/0000100517-26-000186.md) |
| Diluted EPS | $ per share | not reported | [(0.38)](/filings/0000100517-25-000091.md) | [3.96](/filings/0000100517-25-000147.md) | [2.90](/filings/0000100517-25-000193.md) | not reported | [1.16](/filings/0000100517-26-000091.md) | [2.97](/filings/0000100517-26-000139.md) | [2.90](/filings/0000100517-26-000186.md) | not reported | [2.14](/filings/0000100517-26-000091.md) | [2.46](/filings/0000100517-26-000139.md) | [3.14](/filings/0000100517-26-000186.md) |
| Basic EPS | $ per share | not reported | [(0.38)](/filings/0000100517-25-000091.md) | [4.02](/filings/0000100517-25-000147.md) | [2.93](/filings/0000100517-25-000193.md) | not reported | [1.18](/filings/0000100517-26-000091.md) | [3.00](/filings/0000100517-26-000139.md) | [2.93](/filings/0000100517-26-000186.md) | not reported | [2.16](/filings/0000100517-26-000091.md) | [2.48](/filings/0000100517-26-000139.md) | [3.17](/filings/0000100517-26-000186.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.1](/filings/0000100517-26-000023.md) | [8.4](/filings/0000100517-25-000091.md) | [10.9](/filings/0000100517-25-000147.md) | [8.8](/filings/0000100517-25-000193.md) | [8.8](/filings/0000100517-26-000023.md) | [9.4](/filings/0000100517-26-000091.md) | [9.4](/filings/0000100517-26-000139.md) | [6.7](/filings/0000100517-26-000186.md) | [5.9](/filings/0000100517-26-000186.md) | [7.9](/filings/0000100517-26-000091.md) | [10.2](/filings/0000100517-26-000139.md) | [6.6](/filings/0000100517-26-000186.md) |
| Current assets | $bn | [18.5](/filings/0000100517-25-000046.md) | [18.7](/filings/0000100517-24-000079.md) | [20.0](/filings/0000100517-24-000121.md) | [18.6](/filings/0000100517-24-000136.md) | [18.9](/filings/0000100517-26-000023.md) | [20.1](/filings/0000100517-25-000091.md) | [20.3](/filings/0000100517-25-000147.md) | [18.1](/filings/0000100517-25-000193.md) | [16.9](/filings/0000100517-26-000186.md) | [19.4](/filings/0000100517-26-000091.md) | [21.7](/filings/0000100517-26-000139.md) | [20.0](/filings/0000100517-26-000186.md) |
| Total assets | $bn | [71.1](/filings/0000100517-25-000046.md) | [71.9](/filings/0000100517-24-000079.md) | [73.3](/filings/0000100517-24-000121.md) | [72.6](/filings/0000100517-24-000136.md) | [74.1](/filings/0000100517-26-000023.md) | [76.1](/filings/0000100517-25-000091.md) | [77.2](/filings/0000100517-25-000147.md) | [76.3](/filings/0000100517-25-000193.md) | [76.4](/filings/0000100517-26-000186.md) | [80.9](/filings/0000100517-26-000091.md) | [84.6](/filings/0000100517-26-000139.md) | [85.1](/filings/0000100517-26-000186.md) |
| Current liabilities | $bn | [22.2](/filings/0000100517-25-000046.md) | [24.8](/filings/0000100517-24-000079.md) | [25.9](/filings/0000100517-24-000121.md) | [23.4](/filings/0000100517-24-000136.md) | [23.3](/filings/0000100517-26-000023.md) | [25.8](/filings/0000100517-25-000091.md) | [29.0](/filings/0000100517-25-000147.md) | [27.1](/filings/0000100517-25-000193.md) | [26.1](/filings/0000100517-26-000186.md) | [27.8](/filings/0000100517-26-000091.md) | [27.8](/filings/0000100517-26-000139.md) | [26.6](/filings/0000100517-26-000186.md) |
| Long-term debt | $bn | [25.1](/filings/0000100517-25-000046.md) | [23.1](/filings/0000100517-24-000079.md) | [21.7](/filings/0000100517-24-000121.md) | [22.2](/filings/0000100517-24-000136.md) | [21.7](/filings/0000100517-26-000023.md) | not reported | not reported | not reported | [17.2](/filings/0000100517-26-000023.md) | not reported | not reported | not reported |
| Current portion of debt | $bn | [4.0](/filings/0000100517-25-000046.md) | [4.0](/filings/0000100517-24-000079.md) | [4.8](/filings/0000100517-24-000121.md) | [3.3](/filings/0000100517-24-000136.md) | [3.0](/filings/0000100517-26-000023.md) | not reported | not reported | not reported | [4.1](/filings/0000100517-26-000023.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [9.3](/filings/0000100517-26-000023.md) | [9.2](/filings/0000100517-25-000147.md) | [10.5](/filings/0000100517-25-000193.md) | [11.4](/filings/0000100517-25-000193.md) | [12.7](/filings/0000100517-26-000186.md) | [12.6](/filings/0000100517-26-000139.md) | [13.4](/filings/0000100517-26-000186.md) | [14.3](/filings/0000100517-26-000186.md) | [15.3](/filings/0000100517-26-000186.md) | [15.9](/filings/0000100517-26-000139.md) | [16.7](/filings/0000100517-26-000186.md) | [17.8](/filings/0000100517-26-000186.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(910) d](/filings/0000100517-26-000023.md) | [2,848](/filings/0000100517-25-000091.md) | [2,875 d](/filings/0000100517-25-000147.md) | [1,498 d](/filings/0000100517-25-000193.md) | [2,224 d](/filings/0000100517-26-000023.md) | [3,710](/filings/0000100517-26-000091.md) | [2,217 d](/filings/0000100517-26-000139.md) | [1,218 d](/filings/0000100517-26-000186.md) | [1,286 d](/filings/0000100517-26-000023.md) | [4,799](/filings/0000100517-26-000091.md) | [1,610 d](/filings/0000100517-26-000139.md) | [465 d](/filings/0000100517-26-000186.md) |
| Capital expenditure | $m | [2,066 d](/filings/0000100517-26-000023.md) | [1,366](/filings/0000100517-25-000091.md) | [1,164 d](/filings/0000100517-25-000147.md) | [1,410 d](/filings/0000100517-25-000193.md) | [1,675 d](/filings/0000100517-26-000023.md) | [1,233](/filings/0000100517-26-000091.md) | [1,287 d](/filings/0000100517-26-000139.md) | [1,464 d](/filings/0000100517-26-000186.md) | [1,890 d](/filings/0000100517-26-000023.md) | [1,672](/filings/0000100517-26-000091.md) | [1,343 d](/filings/0000100517-26-000139.md) | [2,139 d](/filings/0000100517-26-000186.md) |
| Share repurchases | $m | [0.0 d](/filings/0000100517-26-000023.md) | [0.0](/filings/0000100517-25-000091.md) | [0.0 d](/filings/0000100517-25-000147.md) | [82.0 d](/filings/0000100517-25-000193.md) | [80.0 d](/filings/0000100517-26-000023.md) | [349](/filings/0000100517-26-000091.md) | [240 d](/filings/0000100517-26-000139.md) | [21.0 d](/filings/0000100517-26-000186.md) | [27.0 d](/filings/0000100517-26-000023.md) | [27.0](/filings/0000100517-26-000091.md) | [0.0 d](/filings/0000100517-26-000139.md) | [0.0 d](/filings/0000100517-26-000186.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [327](/filings/0000100517-24-000079.md) | [332](/filings/0000100517-24-000121.md) | [332](/filings/0000100517-24-000136.md) | [328](/filings/0000100517-25-000091.md) | [334](/filings/0000100517-25-000147.md) | [333](/filings/0000100517-25-000193.md) | [333](/filings/0000100517-26-000091.md) | [327](/filings/0000100517-26-000139.md) | [327](/filings/0000100517-26-000186.md) | [327](/filings/0000100517-26-000091.md) | [327](/filings/0000100517-26-000139.md) | [327](/filings/0000100517-26-000186.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 324,894,375 at 2026-10-15, from the cover of the [10-Q filed 2026-10-21](/filings/0000100517-26-000186.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.